Iferanserin

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameIferanserin
Drug Alias Name艾夫色林IferanserinumS-MPECIferanserinaMPEC +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsInternal HemorrhoidsHemorrhoids
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAssembly Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVentrus Biosciences Inc
Active IndicationsN/A
Inactive IndicationsInternal HemorrhoidsHemorrhoids

Other Information

ATC CodeN/A
Related LinksWikipedia